Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Other Non Operating Income: 2016-2024

Historic Other Non Operating Income for Autolus Therapeutics (AUTL) over the last 9 years, with Dec 2024 value amounting to -$1.0 million.

  • Autolus Therapeutics' Other Non Operating Income rose 92.34% to -$911,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 247.79%. This contributed to the annual value of -$1.0 million for FY2024, which is 137.89% down from last year.
  • Latest data reveals that Autolus Therapeutics reported Other Non Operating Income of -$1.0 million as of FY2024, which was down 137.89% from $2.6 million recorded in FY2023.
  • Over the past 5 years, Autolus Therapeutics' Other Non Operating Income peaked at $2.6 million during FY2023, and registered a low of -$1.0 million during FY2024.
  • Moreover, its 3-year median value for Other Non Operating Income was $2.0 million (2022), whereas its average is $1.2 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 1,505.52% in 2022, then slumped by 137.89% in 2024.
  • Autolus Therapeutics' Other Non Operating Income (Yearly) stood at $1.8 million in 2020, then slumped by 107.91% to -$145,000 in 2021, then spiked by 1,505.52% to $2.0 million in 2022, then increased by 29.49% to $2.6 million in 2023, then plummeted by 137.89% to -$1.0 million in 2024.